Allogeneic bone marrow transplantation.
暂无分享,去创建一个
[1] B. Afessa,et al. Outcome of recipients of bone marrow transplants who require intensive-care unit support. , 1992, Mayo Clinic proceedings.
[2] S. Forman,et al. Allogeneic bone marrow transplantation for acute leukemia. , 1990, JAMA.
[3] R. Parkman,et al. Bone marrow transplantation for the treatment of immune deficiency states. , 1990, Bone marrow transplantation.
[4] A. Ribas,et al. What is the role of recombinant colony stimulating factors in bone marrow transplantation? , 1990, Bone marrow transplantation.
[5] E. Thomas,et al. Indications for marrow transplantation in chronic myelogenous leukemia. , 1989, Blood.
[6] C. Parchem,et al. Ambulatory care of the bone marrow transplant patient. , 1988, Seminars in oncology nursing.
[7] L. R. Hill,et al. ALLOGENEIC BONE MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA DURING FIRST COMPLETE REMISSION , 1987, Transplantation.
[8] M. Horowitz,et al. Current status of allogeneic bone marrow transplantation. , 1990, Clinical transplants.
[10] R. Gale,et al. T cell depletion in bone marrow transplantation for leukemia: current results and future directions. , 1988, Bone marrow transplantation.
[11] A. Rimm,et al. Increasing Utilization of Allogeneic Bone Marrow Transplantation , 1992, Annals of Internal Medicine.
[12] A. Rimm,et al. Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. , 1986, Annals of internal medicine.
[13] N. Chao,et al. Bone marrow transplantation. Part I--Allogeneic. , 1989, The Western journal of medicine.
[14] B. Ferrell,et al. The meaning of quality of life for bone marrow transplant survivors Part 1. The impact of bone marrow transplant on quality of life , 1992, Cancer nursing.
[15] W. Woods,et al. Allogeneic bone marrow transplantation for acute leukaemia: comparative outcomes for adults and children , 1988, British journal of haematology.
[16] B. Ballard,et al. Acute complications after bone marrow transplantation. , 1988, Seminars in oncology nursing.
[17] G. Lucarelli,et al. Bone marrow transplantation in patients with thalassemia. , 1990, The New England journal of medicine.
[18] G. Reaman,et al. Acute lymphoblastic leukemia in childhood. , 1985, Pediatric clinics of North America.
[19] Jerry R. Hobbs,et al. REVERSAL OF CLINICAL FEATURES OF HURLER'S DISEASE AND BIOCHEMICAL IMPROVEMENT AFTER TREATMENT BY BONE-MARROW TRANSPLANTATION , 1981, The Lancet.
[20] L. Lum. Immune recovery after bone marrow transplantation. , 1990, Hematology/oncology clinics of North America.
[21] S. Freedman,et al. An overview of bone marrow transplantation. , 1988, Seminars in oncology nursing.
[22] A. Nademanee,et al. Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission , 1991 .
[23] J. Klein,et al. Bone marrow transplantation for Fanconi anemia. , 1995, Blood.
[24] R. Gale,et al. Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies. , 1987, Seminars in hematology.
[25] N. Wedel,et al. Observations using antiendotoxin antibody (E5) as adjuvant therapy in humans with suspected, serious, Gram‐negative sepsis , 1992, Critical care medicine.
[26] J. Reiffers,et al. Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial , 1989, British journal of haematology.
[27] J. Rossi,et al. Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission. , 1990, Bone marrow transplantation.
[28] Eliane Gluckman,et al. Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. , 1989 .
[29] M. Durbin. Bone marrow transplantation: economic, ethical, and social issues. , 1988, Pediatrics.
[30] M. Horowitz,et al. Current status of bone marrow transplantation. , 1989, Clinical transplants.
[31] H. Deeg,et al. Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients. , 1986, Annals of internal medicine.
[32] X. Troussard,et al. Comparison of chemotherapy and autologous and allogeneic transplantation as postinduction regimen in adult acute lymphoblastic leukemia: a preliminary multicentric study. , 1990, Haematology and blood transfusion.
[33] R. Storb,et al. Allogeneic Bone‐Marrow Transplantation , 1983, Immunological reviews.
[34] C. Moravec,et al. The critically ill bone marrow transplant patient. , 1988, Seminars in oncology nursing.
[35] P. Rieker,et al. Pediatric bone marrow transplantation: psychosocial issues for parents after a child's hospitalization , 1995 .
[36] S. Teitelbaum,et al. Successful bone-marrow transplantation for infantile malignant osteopetrosis. , 1980, The New England journal of medicine.
[37] J. Kurtzberg,et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. , 1989, The New England journal of medicine.
[38] E. Conde,et al. Complete recovery of hemopoiesis following bone marrow transplant in a patient with unresponsive congenital hypoplastic anemia (Blackfan-Diamond syndrome). , 1984, Blood.
[39] J. Laver,et al. Marrow transplantation from human leukocyte antigen-identical or haploidentical donors for correction of Wiskott-Aldrich syndrome. , 1991, The Journal of pediatrics.
[40] R. Gale,et al. Prevention and treatment of cytomegalovirus infection and disease after bone marrow transplantation in the 1990s. , 1991, Bone marrow transplantation.
[41] C. Coltman,et al. Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] Y. Beyth,et al. ALPHA-FETOPROTEIN DURING MID-TRIMESTER INDUCED ABORTION , 1975, The Lancet.
[43] J. Nims,et al. Late complications of bone marrow transplant recipients: nursing care issues. , 1988, Seminars in oncology nursing.
[44] Oligonucleotide-based therapeutics , 1991, Nature.
[45] F. Appelbaum,et al. Chemotherapy v marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-up , 1988 .
[46] R. Gale. Potential utilization of a national HLA-typed donor pool for bone marrow transplantation. , 1986, Transplantation.
[47] H. Braine,et al. Specialized cell component therapy. , 1990, Seminars in oncology nursing.
[48] J. Armitage,et al. Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. , 1991, American Journal of Medicine.
[49] D. Jabs,et al. Thalidomide for the treatment of chronic graft-versus-host disease. , 1992, The New England journal of medicine.
[50] E. Herrick,et al. Recipients of bone marrow transplants: making a smooth transition to an ambulatory care setting. , 1990, Oncology nursing forum.
[51] A. Yeager. Pediatric bone marrow transplantation. , 1991, Pediatrics in review.
[52] M. Farrall,et al. Physical and psychosocial functioning of adult survivors of allogeneic bone marrow transplantation. , 1989, Bone marrow transplantation.
[53] K. Sullivan,et al. Graft-versus-leukemia in man: relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantation. , 1987, Progress in clinical and biological research.
[54] G. Dini,et al. Allogeneic bone marrow transplantation versus chemotherapy for childhood acute lymphoblastic leukaemia in second remission. , 1986, Bone marrow transplantation.
[55] R. Storb,et al. Marrow transplantation from unrelated HLA-matched volunteer donors. , 1989, Transplantation proceedings.